National Institute of Health (NIH)

Portfolio · 2

Ultima Genomics

Ultima Genomics is revolutionizing high-throughput DNA sequencing with cost-effective platforms to enable unprecedented advances in biology and improvements in human health.

Led ★ 1 round $4.2M committed Latest: 2020-05

Anima Biotech

Small-molecule mRNA Drug Discovery

1 round $30.0M committed Latest: 2018-01

Investment activity

Q&A

What is the primary sector focus of National Institute of Health (NIH) investments?

National Institute of Health (NIH) primarily focuses its investments in the Health Tech & Life Sciences sector, with one recorded investment in this area.

Can you name a notable company in National Institute of Health (NIH)'s portfolio?

A notable company in National Institute of Health (NIH)'s portfolio is Anima Biotech, which specializes in small-molecule mRNA drug discovery.

What was the most recent investment activity by National Institute of Health (NIH)?

National Institute of Health (NIH) made an investment in January 2018, which was also the month they added a new portfolio company.

What type of funding did Anima Biotech receive from National Institute of Health (NIH)?

Anima Biotech received Seed funding, raising $30M, with National Institute of Health (NIH) participating in the round.